According to recent studies, FX processes an anti-obesity activity mostly by stimulating the expression of uncoupling protein-1 (UCP-1) in WAT (Maeda et al., 2005; Miyashita, 2009; Gammone et al., 2014). The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.